openPR Logo
Press release

“SPARKing" New Antibiotic Drug Discovery

12-04-2017 06:11 PM CET | Science & Education

Press release from: SMi Group

Superbugs and Superdrugs 2018

Superbugs and Superdrugs 2018

Kathy Talkington, Project Director from Pew Charitable Trusts, will discuss the "Shared Platform for Antibiotic Research and Knowledge" when she presents a keynote on "SPARKing" new antibiotic drug discovery at SMi’s 20th annual conference on Superbugs and Superdrugs next March in Central London.

With a background in managing and developing immunization and infectious disease programs and policies, Kathy Talkington is currently responsible for Pew’s work on antibiotics. Pew seeks to address the growing threat of antibiotic resistance by spurring the innovation of new antibiotics and ensuring the appropriate use of antibiotics in both human health care settings and in animals.

"SPARK" is a ground breaking and dynamic platform that brings together antibiotic discovery data and cutting-edge analytics to help scientists tackle the scientific barriers blocking antibiotic discovery.
While the global threat of antibiotic resistance continues to rise, nearly every antibiotic in use today is based on a discovery from more than 30 years ago. SPARK will focus on the unique challenges of finding and designing antibiotics that can defeat drug-resistant Gram-negative bacteria, which are among the hardest-to-treat superbugs.

Other presentations in the featured spotlight on the development of new therapeutics and drugs will include:

• Use of the Pasnas Platform to Enable High Quality Antibacterial Hit Finding presented by Domingo Gargallo-Viola, Chief Scientific Officer, ABAC Therapeutics
• Building a Detailed Computational Network Model of Cell Envelope Biogenesis: A Systems Biology Approach to Developing Antibacterial Drugs (Potentiators) presented by John George, CSO, Oppilotech
• Teaching Old Cephalosporin Dogs New Mechanistic Tricks against MDR Gram-Negative Bacteria Presented by Larry Sutton, Scientific Founder, Gladius Pharmaceuticals
• Novel Virulence Factors Of Acinetobacter Baumannii as Targets for Antibacterial Development presented by Daniel Zurawski, Head, Antibacterial Discovery and Development, Walter Reed Army Institute Of Research

SMi’s 20th Annual conference on Superbugs & Superdrugs will take place on 19th & 20th March 2018 at the Copthorne Tara Hotel, Kensington in London, UK.

Further details including a full speaker line-up and detailed programme are available at www.superbugssuperdrugs.com/openpr

--- end ---

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at www.smi-online.co.uk

2 Floor Harling House
47-51 Great Suffolk Street

Contact Information:
For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release “SPARKing" New Antibiotic Drug Discovery here

News-ID: 844219 • Views: 362

More Releases from SMi Group

Regulatory and Policy Keynote Sessions to be Delivered at the Wearable Injectors …
SMi Reports: Regulation and policy to be a focus topic at the Wearable Injectors and Connected Devices conference this October The Inaugural Wearable Injectors and Connected Devices conference is set to take place on 9th and 10th October 2019 in London, UK. As Europe's only Wearable Injectors Conference, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the
Q&A released with Professor Richard Cowell, US Naval War College & Mr Bruno Bend …
SMi Reports: Senior experts from the US Naval War College and GICAN will be presenting an exclusive briefing at the Maritime Information Warfare conference, in London this November This year’s 3rd Annual Maritime Information Warfare Conference will take place on the 18th- 19th November 2019 in London. SMi group caught up with Professor Richard Crowell, Associate Professor, Joint Military Operations Specialist, US Naval War College and Mr Bruno Bender, Information and
Four Key Reasons to Attend SMi's 2019 Biosimilars Conference
SMi Reports: Conference chair, Michel Mikhail, gives four key reasons to attend the Biosimilars conference this September The 10th Annual Biosimilars conference is set to take place on 25th and 26th September in London, UK. Conference chair, Michel Mikhail, International Expert in Regulatory Affairs, Global Expert Biosimilars, invites prospective delegates to join the conference and hear from prominent speakers and key opinion leaders within the biosimilars industry to share their
Registration is now open for the Pre-filled Syringes and Injectable devices Conf …
SMi Reports: Registration is open for SMi Group’s 12th annual conference and exhibition taking place in January 2020 in London. As Europe’s leading Pre-Filled Syringes conference, the 2020 event will assess innovations in device engineering and components, enhancement of human factors, and optimizing packaging and containment. With the rapid expansion of the PFS market, the regulatory environment is more importance than ever. This year’s programme will look at the EU MDR,

All 5 Releases


More Releases for Superbugs

Four weeks until SMi’s 21st Annual Superbugs & Superdrugs Conference 2019
SMi Reports: Senior industry experts will gather in London to discuss the recent advances made in combating antibiotic resistance. As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. For this reason, the Superbugs & Superdrugs conference, taking
Registration Officially Opens for the 21st Annual Superbugs & Superdrugs Confere …
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicine are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019 (http://www.superbugssuperdrugs.com/openpr). This
Kidney Infection Market | Superbugs | CAGR 5.2% | USA | PDF | PPT | Case Reports …
Kidney infection is a result of infection in the bladder that spreads to the kidney. Most common bacteria causing kidney infection is E. coli. Kidney infections are very common, especially, an aging population. The blood test is performed to make sure that the kidneys are functioning normally. The urine test, called a urinalysis, detects any abnormal cells or proteins that relate to a kidney problem. If the blood and urine
W. J. Wiess and A.S. Lynch invitation to SMi’s Superbugs & Superdrugs USA Conf …
SMi Group reports: William J. Weiss - University of North Texas Health Science Center and Anthony Simon Lynch - Janssen supporting SMi's Superbugs & Superdrugs USA Conference, which is due to take place this November in New Jersey William and Anthony are chairing SMi's Superbugs & Superdrugs USA Conference and encourage all involved in AMR to join experts from multiple disciplines, in the field of infectious disease representing research, regulatory, funding,
Superbugs & Superdrugs USA Conference returns to New Jersey this November
SMi Group reports: agenda released for 3rd annual Superbugs & Superdrugs USA conference Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group is pleased to announce the release of the official agenda for the 3rd annual Superbugs & Superdrugs USA Conference, which is due to take place in Iselin, New Jersey on November 12 - 13, 2018. Antimicrobial resistance, leading to the
Superbugs: Exclusive Interviews Released with ABAC Therapeutics, Alchemy Biomedi …
SMI REPORTS: Expert insight into tackling the scientific, regulatory and economic challenges to combat antimicrobial resistance. It is imperative for medical experts and drug discovery specialists to stay on top of the latest clinical advancements, developments and industry initiatives related to antimicrobial resistance. For this reason, SMi Group have gathered industry experts and government bodies to share their insights at the 20th annual conference on Superbugs and Superdrugs taking place on